Lymphotec Inc.
Records under this name other than the patents Lymphotec Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 4 of 4 · Back to Lymphotec Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,394,368 | Method for producing a composition for promoting survival of transplanted hematopoietic stem cell Term ended Ended no later than May 26, 2024 · From the USPTO record | Term ended | Ended no later than May 26, 2024 | From the USPTO record |
| US 6,692,958 | Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations Term ended Term ended Dec 23, 2021 · From the USPTO record | Term ended | Term ended Dec 23, 2021 | From the USPTO record |
| US 7,105,155 | Method and activated lymphocyte preparations for preventing recurrence of carcinoma Term ended Term ended Sep 4, 2021 · From the USPTO record | Term ended | Term ended Sep 4, 2021 | From the USPTO record |
| US 6,544,514 | Compositions comprising, as the main ingredient, allogenic activated-C4+ cells and method for producing and using the same Term ended Term ended May 22, 2019 · From the USPTO record | Term ended | Term ended May 22, 2019 | From the USPTO record |